Jagsonpal Pharmaceuticals Ltd share price logo

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

BSE: 507789

Small Cap

Pharma Sector

₹212.28

+1.72

(+0.82%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Jagsonpal Pharmaceuticals Stock Performance

as on June 19, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹209.20
    ₹214.00
    downward going graph

    1.45%

    Downside

    0.81%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹155.00
    ₹301.65
    downward going graph

    26.98%

    Downside

    42.10%

    Upside

    downward going graph

Jagsonpal Pharmaceuticals share price movements today

Previous Close
₹210.56
Open
₹209.84
Volume
50.49K
Upper Circuit
₹252.67
Lower Circuit
₹168.45
Day's Low - High
₹209.20 - ₹214.00
52 Week Low - High
₹155.00 - ₹301.65

Jagsonpal Pharmaceuticals Historical Returns

1 Month Return
+ 6.76 %
3 Month Return
+ 16.17 %
1 Year Return
-1.81 %
3 Year Return
+ 36.39 %
5 Year Return
+ 248.15 %

Jagsonpal Pharmaceuticals Fundamentals

as on June 19, 2026 at 4:01 pm IST

Market Cap

₹1,386.23 Cr

Return on Equity (ROE)

18.58

PE Ratio (TTM)

0

Return on capital employed (ROCE)

22.82

Beta (LTM)

0.52

P/B Ratio

5.99

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

33.13

EPS (TTM)

0

Book Value

0

Jagsonpal Pharmaceuticals Technical Analysis

Track how Jagsonpal Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish11
Bullish1
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.05
Bearish
CCI (20)
-209.44
Bullish
RSI (14)
41.04
Neutral
Momentum (10)
-1.2
Bearish
ADI (14)
16.13
Neutral
Ultimate Oscillator (7,14,28)
55.94
Neutral

Moving Averages

Name

Value

Action

SMA (20)
212.59
Bearish
EMA (20)
212.63
Bearish
VWMA (20)
212.6
Bearish
SMA (50)
212.73
Bearish
EMA (50)
212.72
Bearish
SMA (200)
212.84
Bearish
EMA (200)
212.61
Bearish
KAMA (200)
212.75
Bearish
DEMA (200)
213.1
Bearish

Jagsonpal Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jagsonpal Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Jagsonpal Pharmaceuticals Ltd image
Jagsonpal Pharmaceuticals Ltd
NA1,386.2349.63%0.0055268
Sandu Pharmaceuticals Ltd image
Sandu Pharmaceuticals Ltd
NA40.79-1.58%0.50167
Alivus Life Sciences Ltd image
Alivus Life Sciences Ltd
BUY13,010.388.32%0.004852,386
Tyche Industries Ltd image
Tyche Industries Ltd
NA134.07-8.21%0.001265
Brooks Laboratories Ltd image
Brooks Laboratories Ltd
NA200.31-5.34%0.54-1082
See all

Jagsonpal Pharmaceuticals Stock’s Investor Sentiment and Interest

Search interest for Jagsonpal Pharmaceuticals Ltd Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

Jagsonpal Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
60.15
57.83
47.23
43.49
61.44
74.69
74.03
58.56
75.61
74.47
72.95
64.2
Other Income
2
2.27
2.52
2.49
1.44
1.65
25.51
2.77
2.83
3.03
2.98
3.17
Total Income
62.15
60.1
49.76
45.97
62.88
76.35
99.53
61.33
78.44
77.49
75.92
67.37
Expenses
51.52
49.46
43.84
40.82
54.49
58.41
58.19
50.06
61.4
58.03
58.76
53.04
Operating Profit
8.63
8.37
3.39
2.67
6.95
16.28
15.84
8.5
14.21
16.44
14.19
11.16
Operating Profit Margin %
14.35%
14.47%
7.18%
6.14%
11.31%
21.8%
21.4%
14.52%
18.79%
22.08%
19.45%
17.38%
Profit Before Interest, Tax and Depreciation
10.63
10.64
5.92
5.16
8.4
17.94
41.34
11.27
17.04
19.46
17.16
14.33
Interest
0.15
0.22
0.23
0.22
0.22
0.23
0.26
0.26
0.25
0.27
0.26
0.25
Depreciation
0.39
0.46
0.41
0.4
1.07
2.34
2.41
2.31
2.35
2.39
2.39
2.32
Profit Before Tax
10.09
9.96
5.28
4.54
7.11
15.37
38.67
8.7
14.44
16.8
14.51
11.76
Tax Paid
2.61
2.49
1.31
0.98
1.78
3.91
6.68
2.13
3.64
4.24
3.57
2.99
Profit After Tax
7.48
7.47
3.96
3.55
5.33
11.46
31.99
6.58
10.8
12.57
10.95
8.76
Total Net profit including share of profit / Loss from associate company
7.48
7.47
3.96
3.55
5.33
11.46
31.99
6.58
10.8
12.57
10.95
8.76
EPS
2.85
2.84
1.48
1.31
1.94
1.72
4.74
0.98
1.6
1.88
1.67
1.25
Actual EPS
2.85
2.84
1.48
1.31
1.94
1.72
4.74
0.98
1.6
1.88
1.67
1.25
Adjusted EPS
1.14
1.14
0.59
0.52
0.78
0.69
1.9
0.98
1.6
1.88
1.67
1.25
Diluted EPS
2.85
2.84
1.47
1.31
1.93
1.7
4.74
0.98
1.58
1.87
1.65
1.21

Jagsonpal Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
126.53
166.83
158.57
187.95
217.58
236.71
208.7
268.72
287.23
Other Income
0.46
1.43
2.53
4.39
3.43
5.73
9.28
27.88
12
Total Income
126.99
168.25
161.09
192.34
221.01
242.45
217.98
296.59
299.22
Expenses
137.64
157.49
150.04
168.87
192.56
206.02
185.64
217.65
231.23
Operating Profit
-11.11
9.34
8.53
19.08
25.02
30.69
23.06
51.07
56
Operating Profit Margin %
-8.78%
5.6%
5.38%
10.15%
11.5%
12.97%
11.05%
19%
19.5%
Profit Before Interest, Tax and Depreciation
-10.65
10.76
11.06
23.47
28.45
36.43
32.35
78.95
67.99
Interest
0.66
0.75
0.51
0.51
0.29
0.41
0.81
0.96
1.03
Depreciation
0.32
1.02
1.13
1.09
1.53
1.21
1.66
8.13
9.44
Profit Before Tax
-11.63
8.99
9.42
21.87
26.63
34.81
29.88
69.86
57.52
Tax Paid
-0.08
1.79
1.54
4.81
7.78
8.09
7.41
14.5
14.44
Profit After Tax
-11.55
7.22
7.87
17.06
18.86
26.72
22.46
55.36
43.08
Total Net profit including share of profit / Loss from associate company
-11.55
7.22
7.87
17.06
18.86
26.72
22.46
55.36
43.08
EPS
-4.41
2.75
3
6.51
7.2
10.2
8.49
8.26
6.4
Actual EPS
-4.41
2.75
3
6.51
7.2
10.2
8.49
8.26
6.4
Adjusted EPS
-1.76
1.1
1.2
2.6
2.88
4.08
3.4
8.26
6.4
Diluted EPS
-4.41
2.75
3
6.51
7.2
10.2
8.46
8.22
6.31

Jagsonpal Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
9.04
-3.24
-1.58
30.9
11.25
28.22
6.91
46.66
35.17
55.3
Cash Flow from Investing Activities
0.66
41.29
0.46
1.43
-8.7
-2.26
-25.77
-57.67
-24.54
-45.15
Cash Flow from Financing Activities
-6.43
-33.52
-0.6
-6.05
-0.94
-6.82
-17.56
-0.45
-8.9
-11.7
Net Cash Flow
0.52
4.53
-5.55
24.02
-0.46
19.13
-36.42
-11.47
1.71
-1.55

Jagsonpal Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
68.71%
68.48%
68.09%
68.04%
67.97%
67.81%
67.78%
67.65%
67.54%
67.39%
67.89%
69.36%
DII
0.83%
0%
0.85%
0.85%
0.11%
0%
0%
0.05%
0.09%
0.15%
0.22%
0.31%
FII
0.38%
0%
0.73%
1.1%
2.3%
2.1%
2.1%
2.18%
2.12%
2.12%
2.44%
2.46%
Public
30.08%
30.17%
30.33%
30.01%
29.62%
30.08%
30.11%
30.12%
30.25%
30.34%
29.45%
27.87%
Total Outstanding Shares
2,61,98,000
2,62,87,794
2,64,37,794
2,64,57,111
2,64,84,611
2,65,45,962
6,63,98,630
6,65,26,480
6,66,31,254
6,67,81,270
6,69,62,250
6,55,39,150
Total Shareholders
16,041
15,785
16,282
15,748
15,633
18,471
21,085
22,899
24,653
24,895
26,264
24,824

Mutual Funds that own Jagsonpal Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Jagsonpal Pharmaceuticals.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.03%
258

Jagsonpal Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Jagsonpal Pharmaceuticals.

  • Jagsonpal Pharmaceuticals Ltd Earnings Results

    Jagsonpal Pharmaceuticals Ltd’s net profit jumped 33.13% since last year same period to ₹8.76Cr in the Q4 2025-2026. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -20% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Jagsonpal Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 06 May 2025 - translating a dividend yield of 3.56%.

    Read More about Dividends

Indices Featuring Jagsonpal Pharmaceuticals Stock

Check stock indices that include Jagsonpal Pharmaceuticals.

BSE Healthcare

₹47,844.86

0.76 (▲360.19%)

Insights on Jagsonpal Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.44% to 2.46% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 67.89% to 69.36% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, JAGSNPHARM stock has moved down by -0.4%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 29.45% to 27.87% in Jun 2026 quarter

About Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals was established in 1978 by J. S. Kochhar in Faridabad, Haryana. The company strategises by combining its products into seven groups for effective sales and cost effectiveness. Through its subsidiary Jagsonpal Exports India Pvt Ltd. it is setting up a new multipurpose plant to manufacture modern drugs and formulations, partnered with Fidia Spa Italy and B Spofola Czechoslovakia. It is also involved in RD activities to upgrade the manufacturing process, packaging and cost control. In 1994, Aresco Financial Services, a financial company, was also established by the company. It has tied up with Makhteshim Chemical Works to acquire the marketing rights of an antioxidant product and Lycored Natural Products Industries LNP, from Israel, to launch a natural Lycopene product in India and South East Asia. Despite sluggish markets, low industry growth rate and severe competition from drug majors, Jagsonpal Pharmaceuticals still saw a sales growth of 15%, totaling Rs. 136.52 Crores, with a net profit of 8%, totalling Rs. 10.15 Crores. The company has implemented various measures to sustain this growth for future opportunities.

Revenue: ₹64.20Cr as on March 2026 (Q4 FY26)
Net Profit: ₹8.76Cr as on March 2026 (Q4 FY26)
Listing date: 13 Sep, 1996
Chairperson Name: Harsha Raghavan
OrganisationJagsonpal Pharmaceuticals Ltd
HeadquartersGurgaon
IndustryPharmaceuticals
CEOHarsha Raghavan
E-voting on sharesClick here to vote

FAQs

What is Jagsonpal Pharmaceuticals share price today?

Jagsonpal Pharmaceuticals share price today stands at ₹212.28 as on at the close of the market. Jagsonpal Pharmaceuticals share today touched a day high of ₹214 and a low of ₹209.2.

What is the 52 week high and 52 week low range for Jagsonpal Pharmaceuticals share?

Jagsonpal Pharmaceuticals touched a 52 week high of ₹301.65 and a 52 week low of ₹155. Jagsonpal Pharmaceuticals share price today i.e. is closed at ₹212.28, which is -29.63% down from its 52 week high and 36.95% up from its 52 week low.

What is Jagsonpal Pharmaceuticals's market capitalisation today?

Jagsonpal Pharmaceuticals market capitalisation is ₹1,386.23 Cr as on .

How to buy Jagsonpal Pharmaceuticals shares?

To buy Jagsonpal Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for JAGSNPHARM or Jagsonpal Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Jagsonpal Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Jagsonpal Pharmaceuticals trading volume today?

Jagsonpal Pharmaceuticals trading volume is 50.49K as on . This means that 50.49K shares of Jagsonpal Pharmaceuticals were bought and sold on the stock market during today's trading session.